Effect of Metformin Glycinate on Postprandial Lipemia, Glycemic Control and Oxidation Markers in Type 2 Diabetes Patients
Phase of Trial: Phase II/III
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Metformin (Primary)
- Indications Lipid metabolism disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Laboratorios Silanes
- 26 Jan 2018 Planned End Date changed from 1 Dec 2015 to 1 Aug 2020.
- 26 Jan 2018 Planned primary completion date changed from 1 Jun 2015 to 1 Apr 2020.
- 26 Jan 2018 Status changed from not yet recruiting to recruiting.